Literature DB >> 2556944

Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern.

M Sakamoto1, S Hirohashi, H Tsuda, Y Shimosato, M Makuuchi, Y Hosoda.   

Abstract

Two separate nodular lesions of hepatocellular carcinoma (HCC) were surgically removed from a patient with positive serum hepatitis B surface antigen. Southern blot analysis of DNA from the two separate HCC lesions showed different restriction patterns of integrated hepatitis B virus DNA, indicating their independent origins. The two lesions were composed mainly of poorly differentiated HCC; however, well-differentiated HCC was also observed in the periphery of the lesions. This histological finding is consistent with the multistep and independent development of HCC in each site of the liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556944     DOI: 10.1097/00000478-198912000-00009

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  21 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Current management of patients with hepatocellular carcinoma.

Authors:  Tatsuo Kanda; Sadahisa Ogasawara; Tetsuhiro Chiba; Yuki Haga; Masao Omata; Osamu Yokosuka
Journal:  World J Hepatol       Date:  2015-07-28

3.  Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.

Authors:  Osakuni Morimoto; Hiroaki Nagano; Atsushi Miyamoto; Yoshiyuki Fujiwara; Motoi Kondo; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Hiroshi Wada; Bazarragchaa Damdinsuren; Shigeru Marubashi; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  A possible prototype of multifocal recurrence after liver resection of hepatocellular carcinoma: report of a case.

Authors:  M Yamamoto; M Mogaki; M Matsuda; Y Matsumoto
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

5.  Intrahepatic distant metastasis and metachronous multicentric occurrence in solitary hepatocellular carcinoma of less than five centimeters in diameter.

Authors:  M Yamamoto; M Matsuda; Y Iimuro; H Fujii; K Nagahori; T Ainota
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 6.  Multistep human hepatocarcinogenesis: correlation of imaging with pathology.

Authors:  Masatoshi Kudo
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

7.  Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging.

Authors:  Rieko Shinmura; Osamu Matsui; Masumi Kadoya; Satoshi Kobayashi; Noboru Terayama; Junichiro Sanada; Hiroshi Demachi; Toshifumi Gabata
Journal:  Eur Radiol       Date:  2008-04-02       Impact factor: 5.315

8.  The indications for tumor mass reduction surgery and subsequent multidisciplinary treatments in stage IV hepatocellular carcinoma.

Authors:  M Yamamoto; H Iizuka; M Matsuda; K Nagahori; K Miura; J Itakura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

9.  Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma.

Authors:  Deshui Jia; Ying Jing; Zhenfeng Zhang; Li Liu; Jie Ding; Fangyu Zhao; Chao Ge; Qifeng Wang; Taoyang Chen; Ming Yao; Jinjun Li; Jianren Gu; Xianghuo He
Journal:  Cell Res       Date:  2013-12-03       Impact factor: 25.617

10.  Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence.

Authors:  Hiroyuki Sugo; Shunji Futagawa; Tomoe Beppu; Masaki Fukasawa; Kuniaki Kojima
Journal:  World J Surg       Date:  2003-11-05       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.